Although rare, superior mesenteric artery aneurysms (SMAAs) are life-threatening due to their high rupture rate. We herein report a case involving an 80-year-old man who presented with acute cholecystitis and who was incidentally found to have a 36-mm peripheral SMAA. A surgical intervention was performed, involving resection of the SMAA and reconstruction of the superior mesenteric artery (SMA) using an autologous vein graft. Intraoperative and histological findings indicated an inflammatory aneurysm, and the postoperative course was uneventful. We believe that resection of the aneurysm and reconstruction of the SMA is the preferred procedure for SMAAs to maintain adequate mesenteric circulations.We herein report a case of a 20-year-old man with aortic regurgitation (AR), coarctation of the aorta (CoA), and patent ductus arteriosus (PDA). The preoperative ankle-brachial pressure index was 0.56 in bilateral extremities. Enhanced computed tomography revealed CoA-postductal type. We decided to perform a two-stage surgery thoracic endovascular aortic repair (TEVAR) for CoA and PDA and then open surgery for AR. TEVAR was successfully performed with deployment of the stent graft at a 31-mm diameter subsequent to balloon dilation. At 8 days after TEVAR, the patient underwent aortic valve replacement via median sternotomy and was discharged without a complication.Objective We sought to clarify the interface pressure (IP) when using a tubular elastic bandage (TEB) and examine the possibility for TEBs to provide IPs comparable to those provided by anti-thrombotic stockings. Materials and Methods In 40 healthy patients, IPs were measured at the level of calf at its maximum diameter (C) and transition of the medial gastrocnemius muscle into the Achilles tendon (B1) while a single or double layer of TEBs (17.5 cm in circumference) were applied with the patient in a supine position. Results Including both the C and B1 levels, circumferences and IPs showed a good correlation (single layer; r=0.72, double layer; r=0.75). The IP obtained with a single layer of TEB at the C level (median, 17 mmHg [range, 12-23 mmHg]) was higher than that at the B1 level (14 mmHg [11-18 mmHg], p less then 0.001). When double-layer TEB was used, the IP at B1 level increased to 18 (14-23) mmHg (p less then 0.001 vs. single layer). Conclusion Considering the characteristics of TEBs and using a single or double layer appropriately, creating a pressure profile mimicking that of an anti-thrombotic stocking seemed to be feasible when using a TEB.Objectives This study aimed to evaluate early- and long-term outcomes in patients who undergo muscle flap coverage (MFC) for prosthetic graft infections (PGIs) at the groin or thigh. Materials and Methods We retrospectively retrieved and analyzed data on infected wound cures, recurrence, graft and limb salvage, and survival of patients who underwent MFC for PGI at the groin or thigh between 2000 and 2018. Results There were eight patients in our cohort six had groin PGIs and two had thigh PGIs. Moreover, of these patients, seven were treated from sartorius muscles and one from a gracilis muscle. The indicated wounds healed in all eight patients, but two patients died during hospitalization. Three patients suffered recurrence within 8 months, one of which overcame the infection and achieved wound cure without graft removal, with negative pressure wound therapy. No patients lost their limbs during the follow-up term (mean, 24 months; range, 1-60 months). Finally, four patients (50%) survived without removal of the infected graft for longer than 2 years. Conclusion MFC can be a curative treatment for PGI, but there remains a possibility of a recurring infection thereafter.Objective Devices that can noninvasively measure central and peripheral venous pressures with relative ease and in a short time were developed, but the resolution of the data that can be recorded with these devices is limited to 50 mmHg. Materials and Methods We aimed to develop a system that could overcome this limitation. We used an innovative noninvasive controlled compression sonography device that could theoretically measure pressures higher than 200 mmHg. First, to validate the accuracy of our device, an in vitro study was conducted. Then, the values measured by our system were compared to conventionally obtained measurements of central venous, peripheral venous, and brachial artery pressures. Finally, regression analyses were used to determine the correlations between measurements obtained from different devices. Results With our device, the measurement of venous and arterial pressures required only 3 to 15 sec. All regression analyses revealed a significant statistical correlation between measurements, although the correlation coefficient was relatively low for arterial pressure. Conclusion For venous pressure, our system can provide measurements that could not be measured noninvasively with conventional methods. Regarding arterial pressure, although our system could measure systolic pressure, further studies are needed to confirm the clinical efficacy of our device.Objective This paper documents our experience using the Cleaner XT™ device (Argon Medical Devices, Plano, TX, USA) for pharmacomechanical thrombolysis (PMT) of thrombosed haemodialysis arteriovenous grafts (AVG) and fistulas (AVF). Materials and Methods This was a retrospective case series (n=17) over six months at Singapore General Hospital. We evaluated demographics, procedural data, technical and procedural success, patency rates and complications. Results There were 8 (47%) males and the patients' mean age was 66 (± 5.7) years. The mean age of AVF/AVG was 1605 (± 1099) days. All procedures were performed under local anaesthetic. PMT was performed within a mean time of 40 (±34.3) hours from the presentation. Technical, clinical and procedural success was 15/17 (88%). The thrombolysis agents used were tissue plasminogen activator (52.9%) and urokinase (41.2%). Mean primary patency time was 114 (± 116) days, with a 65% 1-month and 47% 3-month primary patency rates. AZ628 The mean secondary patency time was 155 (±132) days, with 76% one-month and 65% three-month secondary patency rates, respectively.